Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

This industry’s lobbying juggernaut has its claws in both sides of the aisle in Congress. In 2022, pharmaceutical and health ...

As part of an Ontario Ministry of Health mandate to address the crisis, naloxone (also known by the brand name Narcan) is ...

From construction to supporting the city's downtown and responding to homelessness and housing, fast-growing London will ...

Bracebridge Ontario Provincial Police (OPP) is issuing a caution to members of the public about the potential of a deadly ...

Coun. Jeff Leiper says a clinic in Hintonburg that offers prescription opioids to fentanyl users is harming the community and ...

A newly created Primary Care Action Team has a lofty goal: to ensure all Ontarians have access to primary health care within ...

The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma ...

The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...

Antimicrobial resistance (AMR) is rapidly becoming a global crisis that could claim 40 million lives by 2050. In this video, we explore why pharmaceutical companies are reluctant to develop new ...

New mortgage rules, new contribution limits for TFSA, RRSP and CPP, and increases to hourly minimum wages are among the new ...

TORONTO (Reuters) -The Canadian dollar weakened against its U.S. counterpart on Friday and extended a streak of weekly declines as investors weighed multiple headwinds for the commodity-linked ...